• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alnylam Pharmaceuticals Inc

+ Add to Watchlist

ALNY:US

95.2050 USD 1.7850 1.91%

As of 20:10:00 ET on 01/26/2015.

Snapshot for Alnylam Pharmaceuticals Inc (ALNY)

Open: 93.4300 Day's Range: 93.4100 - 96.2000 Volume: 861,859
Previous Close: 93.4200 52wk Range: 47.0300 - 111.4900 1-Yr Rtn: +17.46%

Stock Chart for ALNY

No chart data available.
  • ALNY:US 95.2500
  • 1D
  • 1M
  • 1Y
93.4200
Interactive ALNY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.2689
Est. EPS (USD) (12/2014) -4.8000
Est. PEG Ratio -
Market Cap (M USD) 7,862.70
Shares Outstanding (M) 82.59
30 Day Average Volume 816,523
Price/Book (mrq) 8.0710
Price/Sale (ttm) 178.1890
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALNY

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.

John M MaraganoreChief Executive OfficerBarry E GreenePresident/COO
Akshay K VaishnawExec VP/Chief Medical OfficerKaren AndersonSenior VP/Chief Human Resources Ofcr
More Company Profile & Key Executives for ALNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil